FieldMJ,LohrKN., 1990.Clinical practice guidelines: directions for a new program, 1 -56
BrouwersMC,KhoME,BrowmanGP,BurgersJS,CluzeauF,FederG, 2010.AGREE II: advancing guideline development, reporting and evaluation in health care,Can Med Asso J 182 839 -42
RiazS,AlamM,UmerM., 2006.Frequency of osteomalacia in elderly patients with hip fractures,J Pak Med Asso 56 273 -76
HarinarayanC,Natl Med, 2004.What's in a name-25 (OH) D or 25 (OH) D3, 17 114 -15
HamiltonBE,MartinJA,VenturaSJ, 2010.Births: Preliminary data for 2008, 58 1 -18
BrouwersMC,KhoME,BrowmanGP,BurgersJS,CluzeauF,FederG, 2010.Development of the AGREE II, part 2: assessment of validity of items and tools to support application,Cana Med Assoc J 182 472 -78
BrouwersMC,KhoME,BrowmanGP,BurgersJS,CluzeauF,FederG, 2010.Development of the AGREE II, part 1: performance, usefulness and areas for improvement,Can Med Asso J 182 1045 -52
LauE,SambrookP,SeemanE,LeongK,LeungP,DelmasP, 2006.Guidelines for diagnosing, prevention and treatment of osteoporosis in Asia,Aplar J of Rheu 9 24 -36
FaulF,ErdfelderE,LangAG,BuchnerAG, 2007.Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences,Beh Res Meth 39 175 -91
BrouwersMC,BrowmanG,BurgersDJ,CluzeauF,DavisD,FederG, 2009.Appraisal of guidelines for research & evaluation (AGREE - II) instrument -, 1 -11
WoolfS,SchünemannHJ,EcclesMP,GrimshawJM, 2012.Developing clinical practice guidelines: types of evidence and outcomes; values and economics, synthesis, grading, and presentation and deriving recommendations,Implementation Sci 7 61 -
GardnerB,DavidsonR,McAteerJ,MichieS., 2009.A method for studying decision-making by guideline development groups,Implementation Sci 4 48 -
SteinbergE,GreenfieldS,WolmanDM,MancherM,GrahamR., 2011.Clinical practice guidelines we can trust, -
QaseemA,ForlandF,MacbethF,OllenschlägerG,PhillipsS,van der Wees P. Guidelines International, 2012.Network: toward international standards for clinical practice guidelines,Ann of Int Med 156 525 -31
Als-NielsenB,ChenW,GluudC,KjaergardLL, 2003.Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events?,The J of the Am Med Asso 290 921 -28
LexchinJ,BeroLA,DjulbegovicB,ClarkO, 2003.Pharmaceutical industry sponsorship and research outcome and quality: systematic review,Bol Med 326 1167 -70
DetskyAS, 2006.Sources of bias for authors of clinical practice guidelines,Can Med Asso J 175 1033 -
ShaneyfeltTM,CentorRM, 2009.Reassessment of clinical practice guidelines: go gently into that good night,The J of the Ame Med Asso 301 868 -69
SnidermanAD,FurbergCD, 2009.Why guideline-making requires reform,The J of the Ame Med Asso 301 429 -31
EcclesMP,GrimshawJM,ShekelleP,SchünemannHJ,WoolfS. Developing, 2012.clinical practice guidelines: target audiences, identifying topics for guidelines, guideline group composition and functioning and conflicts of interest,Implementation Sci 7 60 -
BoydEA,BeroLA, 2000.Assessing faculty financial relationships with industry: a case study,The J of the Ame Med Asso 284 2209 -14
CampbellEG, 2007.Doctors and drug companies-scrutinizing i nf l u e nt i a l re l at i o n s h i ps . N ew E n g J o f M e d, 357 1796 -97
JacobsAK,LindsayBD,BellandeBJ,FonarowGC,NishimuraRA,ShahPM, 2004.Task force 3: Disclosure of relationships with commercial interests: policy for educational activities and publications,Circulation 110 2524 -28